Publication:
Cytochalasin E: Inhibition of intestinal glucose absorption in the mouse

dc.contributor.authorT. Glinsukonen_US
dc.contributor.authorB. Kongsuktrakoonen_US
dc.contributor.authorC. Toskulkaoen_US
dc.contributor.authorS. Sophasanen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-12T07:37:38Z
dc.date.available2018-10-12T07:37:38Z
dc.date.issued1983-01-01en_US
dc.description.abstractIn situ glucose absorption in the mouse was significantly inhibited by cytochalasin E. Cytochalasin E (5 mg/ml) also inhibited glucose absorption up to 55.5% in mouse jejunum in vitro. During its inhibition transmural potential difference (PD) was increased from -7.4 to -0.4 mV, together with a decrease in glucose accumulation in the intestinal tissues. Furthermore, it was also found that cytochalasin E induced an alteration in Kmvalue from 2.9 · 10-3to 4.0 · 10-2M and a constant Vmaxvalue of 55.5 smmol/100 mg wet wt tissue/min. It is postulated that cytochalasin E is a possible competitive inhibitor of glucose at the receptor sites of carriers on the microvillar membrane of the intestinal absorptive cells. © 1983.en_US
dc.identifier.citationToxicology Letters. Vol.15, No.4 (1983), 341-348en_US
dc.identifier.doi10.1016/0378-4274(83)90154-6en_US
dc.identifier.issn03784274en_US
dc.identifier.other2-s2.0-0020692484en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/30548
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020692484&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleCytochalasin E: Inhibition of intestinal glucose absorption in the mouseen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020692484&origin=inwarden_US

Files

Collections